CooperVision

Study Published in Peer-Reviewed Journal Shows MiSight® 1 day Provides Desirable Myopic Defocus for Higher Prescriptions

A newly published study in a peer-reviewed journal reinforces prescribing confidence in CooperVision’s MiSight® 1 day soft contact lenses for...

Read More
CooperVision

CooperVision Celebrates Five Years of MiSight® 1 day FDA Approval at Academy 2024 International Reception

CooperVision is once again sponsoring the Academy 2024 International Reception for eye care professionals (ECPs) from around the world Scheduled for...

Read More